Lv11
30 积分 2021-07-05 加入
Progress of antibody–drug conjugates (ADCs) targeting c-Met in cancer therapy; insights from clinical and preclinical studies
3小时前
已完结
Unlocking the potential of bispecific ADCs for targeted cancer therapy
5个月前
已完结
BL-B01D1, a first-in-class EGFR–HER3 bispecific antibody–drug conjugate, in patients with locally advanced or metastatic solid tumours: a first-in-human, open-label, multicentre, phase 1 study
5个月前
已完结
A systematic review of antibody-drug conjugates and bispecific antibodies in head and neck squamous cell carcinoma and nasopharyngeal carcinoma: Charting the course of future therapies
7个月前
已完结
BL-B01D1, a first-in-class EGFR–HER3 bispecific antibody–drug conjugate, in patients with locally advanced or metastatic solid tumours: a first-in-human, open-label, multicentre, phase 1 study
7个月前
已完结
Xaluritamig, a STEAP1 × CD3 XmAb 2+1 Immune Therapy for Metastatic Castration-Resistant Prostate Cancer: Results from Dose Exploration in a First-in-Human Study
7个月前
已完结
Targeting advanced prostate cancer with STEAP1 chimeric antigen receptor T cell and tumor-localized IL-12 immunotherapy
7个月前
已完结
Cancer incidence and mortality in China, 2022
8个月前
已完结
Effective flow-through polishing strategies for knob-into-hole bispecific antibodies
9个月前
已完结
Excellent removal of knob-into-hole bispecific antibody byproducts and impurities in a single-capture chromatography
9个月前
已完结
皖公网安备34019202002308
